NOC2L-TCEB3 Fusion FISH Probe
The NOC2L-TCEB3 Fusion FISH Probe is used to confirm a fusion of the NOC2L and TCEB3 genes. The fusion of the NOC2L and TCEB3 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NOC2L-TCEB3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NOC2L-TCEB3-20-AQAQ | 20 (40 μL) | 200 μL |
|
NOC2L Gene Summary
Histone modification by histone acetyltransferases (HAT) and histone deacetylases (HDAC) can control major aspects of transcriptional regulation. NOC2L represents a novel HDAC-independent inhibitor of histone acetyltransferase (INHAT) (Hublitz et al., 2005 [PubMed 16322561]).[supplied by OMIM, Mar 2008]
Gene Name: NOC2 Like Nucleolar Associated Transcriptional Repressor
Chromosome: CHR1: 879582 -894679
Locus: 1p36.33
Gene Diseases
The NOC2L TCEB3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|